๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Double placebo design in a prevention trial for Alzheimer's disease

โœ Scribed by Barbara K Martin; Curtis L Meinert; John C.S Breitner; the ADAPT Research Group

Book ID
114186897
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
57 KB
Volume
23
Category
Article
ISSN
0197-2456

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A double-blind, placebo-controlled singl
A double-blind, placebo-controlled single dose trial of intravenous flumazenil in Alzheimer's disease
โœ Lisa Templeton; Andrew Barker; Keith Wesnes; David Wilkinson ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 203 KB ๐Ÿ‘ 2 views

Benzodiazepine agonists have been shown to reduce cognitive functioning by producing attentional deยฎcits similar to those produced by muscarinic antagonists. It has therefore been postulated that benzodiazepine antagonists may improve cognitive function in patients with Alzheimer's disease by indire